{"nctId":"NCT01072331","briefTitle":"Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus","startDateStruct":{"date":"2010-02"},"conditions":["Type 2 Diabetes Mellitus"],"count":99,"armGroups":[{"label":"MP-513 10 mg, once a day, for 4 weeks","type":"EXPERIMENTAL","interventionNames":["Drug: MP-513"]},{"label":"MP-513 20 mg, once a day, for 4 weeks","type":"EXPERIMENTAL","interventionNames":["Drug: MP-513"]},{"label":"Placebo of MP-513","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo of MP-513"]}],"interventions":[{"name":"MP-513","otherNames":[]},{"name":"MP-513","otherNames":[]},{"name":"Placebo of MP-513","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients who are 20 - 75 years old\n* Patients who are under dietary management and taking therapeutic exercise for diabetes over 8 weeks before administration of investigational drug\n* Patients whose HbA1c is â‰¥6.5% and \\<10.0%\n* Patients who were not administered diabetes therapeutic drugs prohibited for concomitant use within 8 weeks before administration of investigational drug.\n\nExclusion Criteria:\n\n* Patients with type 1 diabetes, diabetes mellitus caused by pancreas impairment, or secondary diabetes (Cushing disease, acromegaly, etc)\n* Patients who are accepting treatments of arrhythmias\n* Patients with serious diabetic complications\n* Patients who are the excessive alcohol addicts\n* Patients with severe hepatic disorder or severe renal disorder.\n* Patients who are pregnant, lactating, and probably pregnant patients, and patients who can not agree to contraception","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in 2-h Postprandial Glucose (Breakfast, Lunch and Dinner)","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-56.2","spread":"5.5"},{"groupId":"OG001","value":"-43.7","spread":"5.8"},{"groupId":"OG002","value":"-5.5","spread":"6.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-43.1","spread":"6.5"},{"groupId":"OG001","value":"-36.9","spread":"7.0"},{"groupId":"OG002","value":"-8.3","spread":"7.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-41.8","spread":"5.4"},{"groupId":"OG001","value":"-40.5","spread":"5.7"},{"groupId":"OG002","value":"-4.3","spread":"5.8"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in 24-h Mean Glucose","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-34.722","spread":"3.885"},{"groupId":"OG001","value":"-30.921","spread":"4.005"},{"groupId":"OG002","value":"-5.402","spread":"4.037"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Plasma Glucose","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-20.7","spread":"2.7"},{"groupId":"OG001","value":"-20.5","spread":"2.8"},{"groupId":"OG002","value":"-6.9","spread":"2.8"}]}]}]},{"type":"PRIMARY","title":"Change From Baseline in Plasma Glucose Area Under the Curve (AUC) 0 to 2h (Breakfast, Lunch and Dinner)","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-82.114","spread":"8.028"},{"groupId":"OG001","value":"-75.437","spread":"8.321"},{"groupId":"OG002","value":"-8.950","spread":"8.294"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-92.947","spread":"10.592"},{"groupId":"OG001","value":"-86.843","spread":"11.328"},{"groupId":"OG002","value":"-6.884","spread":"11.184"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-75.204","spread":"9.660"},{"groupId":"OG001","value":"-85.192","spread":"10.158"},{"groupId":"OG002","value":"-11.271","spread":"10.218"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":34},"commonTop":["Nasopharyngitis","Glucose urine present","Upper respiratory tract inflammation","Protein urine present","Blood triglycerides increased"]}}}